These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6309797)
21. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958 [TBL] [Abstract][Full Text] [Related]
22. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Huang TF; Liu CZ; Ouyang CH; Teng CM Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330 [TBL] [Abstract][Full Text] [Related]
23. Factor V binding to human platelets: the role of divalent cations and of platelet preparatory methods. Ittyerah TR; Rawala R; Colman RW Thromb Res; 1982 Apr; 26(1):59-71. PubMed ID: 7101247 [TBL] [Abstract][Full Text] [Related]
24. Ca2+ transport across the platelet plasma membrane. A role for membrane glycoproteins IIB and IIIA. Brass LF J Biol Chem; 1985 Feb; 260(4):2231-6. PubMed ID: 3156129 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets. Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716 [TBL] [Abstract][Full Text] [Related]
26. Absent platelet aggregation with normal fibrinogen binding in basset hound hereditary thrombopathy. Patterson WR; Estry DW; Schwartz KA; Borchert RD; Bell TG Thromb Haemost; 1989 Nov; 62(3):1011-5. PubMed ID: 2512673 [TBL] [Abstract][Full Text] [Related]
27. Changes in both calcium pool size and morphology of human platelets incubated in various concentrations of calcium ion. Calcium-specific bleb formation on platelet-membrane surface. Tsai WJ; Chen JC; Wang CT Biochim Biophys Acta; 1988 May; 940(1):105-20. PubMed ID: 3130103 [TBL] [Abstract][Full Text] [Related]
28. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation. Peerschke EI J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399 [TBL] [Abstract][Full Text] [Related]
29. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. Coller BS; Peerschke EI; Scudder LE; Sullivan CA J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the Fc gamma receptor on human platelets. King M; McDermott P; Schreiber AD Cell Immunol; 1990 Jul; 128(2):462-79. PubMed ID: 2141549 [TBL] [Abstract][Full Text] [Related]
31. Evidence that plasma fibrinogen and platelet membrane GPIIb-IIIa are involved in the adhesion of platelets to an artificial surface exposed to plasma. Nagai H; Handa M; Kawai Y; Watanabe K; Ikeda Y Thromb Res; 1993 Sep; 71(6):467-77. PubMed ID: 8134906 [TBL] [Abstract][Full Text] [Related]
32. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques. Kornecki E; Tuszynski GP; Niewiarowski S Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105 [TBL] [Abstract][Full Text] [Related]
33. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets. Timmons S; Kloczewiak M; Hawiger J Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354 [TBL] [Abstract][Full Text] [Related]
34. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex]. Caen JP; Rosa JP; Soria C; Boizard B C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690 [TBL] [Abstract][Full Text] [Related]
35. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay. Disdier M; Legrand C; Bouillot C; Dubernard V; Pidard D; Nurden AT Thromb Res; 1989 Mar; 53(6):521-33. PubMed ID: 2499944 [TBL] [Abstract][Full Text] [Related]
36. The binding of human blood platelets to fibrinogen-, fibronectin-, and Arg-Gly-Asp-derivatized Sephadex G-10. Besselink GA; Beugeling T; Beernink R; Poot AA; Van Aken WG; Bantjes A J Biomater Sci Polym Ed; 1995; 7(7):551-62. PubMed ID: 8924422 [TBL] [Abstract][Full Text] [Related]
37. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. Hwang SB J Biol Chem; 1988 Mar; 263(7):3225-33. PubMed ID: 2830276 [TBL] [Abstract][Full Text] [Related]
38. Epinephrine-induced aggregation of rabbit platelets refractory to ADP. Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167 [TBL] [Abstract][Full Text] [Related]
39. Studies of the origin of platelet-associated fibrinogen. Karpatkin M; Howard L; Karpatkin S J Lab Clin Med; 1984 Aug; 104(2):223-37. PubMed ID: 6205112 [TBL] [Abstract][Full Text] [Related]
40. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. Kornecki E; Niewiarowski S; Morinelli TA; Kloczewiak M J Biol Chem; 1981 Jun; 256(11):5696-701. PubMed ID: 6263888 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]